Navigation Links
Palatin Technologies, Inc. March 31, 2011 Quarter Results; Teleconference and Webcast to be Held on May 16, 2011
Date:5/12/2011

CRANBURY, N.J., May 12, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will host a conference call and webcast on May 16, 2011 at 11:00 a.m. Eastern Time to discuss its quarter ended March 31, 2011 financial results and its programs, focusing on the upcoming start of its Phase 2 clinical trial with bremelanotide for women with female sexual dysfunction.  Schedule for the Financial Results Press Release, Conference Call / WebcastQ3 Fiscal Year 2011 Conference Call-Live

5/16/2011 at 11:00 a.m. ETDomestic Dial-In Number

1-866-316-1363International Dial-In Number

1-913-312-0861Pass code

2950108Q3 Fiscal Year 2011 Conference Call-Replay

5/16-5/23/2011Domestic Dial-In Number

1-888-203-1112International Dial-In Number

1-719-457-0820Pass code

2950108Webcast Live and Replay Access

http://www.palatin.comThe webcast and replay can be accessed by logging on to the “Investor/Media Center-Webcasts” section of Palatin’s website at http://www.palatin.comAbout Palatin Technologies, Inc.Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin Technologies' website at www.palatin.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. FDA Clears Palatin Technologies IND Filing to Commence Clinical Studies for Asthma
2. Palatin Technologies, Inc. Closes $23 Million Public Offering
3. Palatin Technologies Listing Compliance Plan Accepted by NYSE Amex
4. Palatin Technologies Receives Non-Compliance Letter from NYSE Amex
5. Palatin Technologies to Present at 9th Annual BIO Investor Forum
6. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
7. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
10. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
11. Palatin Technologies to Present at 8th Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... CORAL SPRINGS, Florida , May 25, 2016 /PRNewswire/ ... Marijuana Business Conference & Expo earlier this month, the ... undeniable. As revenues continue to climb into the billions, ... to the newly released 4th Edition State of Legal ... New Frontier, a cannabis-focused data-analysis firm, much of the ...
(Date:5/25/2016)... 25, 2016 MedDay, a biotechnology company ... an oral presentation entitled "High doses of biotin in progressive ... be given by Professor Ayman Tourbah , Principal Investigator ... the European Academy of Neurology (EAN) in Copenhagen, ... 3" will take place on Sunday, 29 May 2016 from ...
(Date:5/24/2016)... May 24, 2016 Niederländische ... gebracht, die es Ärzten erlaubt, ihre Expertise weltweit ... MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion und ... kommunizieren. Mediziner in Europa, Afrika, Asien und den ... für die Plattform registriert. Information und ...
Breaking Medicine Technology:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... industry leader in Blood Pressure products . , High blood pressure affects ... effects. Left untreated, high blood pressure can lead to heart disease, stroke, kidney ...
(Date:5/26/2016)... ... May 26, 2016 , ... With long-term ... Vice President of Business Intelligence and Informatics, effective immediately. http://www.fluidedgeconsulting.com , ... teams as a healthcare business and financial strategist for over 20 years. ...
(Date:5/25/2016)... ... May 26, 2016 , ... The 12th session of ... 7.30pm PST at HP in Palo Alto, CA. This Bay Area biotech event will ... by clinical trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract Research Organization ...
(Date:5/25/2016)... ... May 25, 2016 , ... Extremity Healthcare, Incorporated has implemented ... patient check-in and post visit surveys. , “The Phreesia front desk system has ... revolutionized the check-in process for our clinic network, providing a world class administration ...
(Date:5/25/2016)... ... 25, 2016 , ... Serenity Recovery, a holistic treatment center ... of the many supplemental program options offered at their rehabilitation facility, this time ... Black Belt in the Shorin-ryu style of Karate that originated in Okinawa, Japan, ...
Breaking Medicine News(10 mins):